US stocks fluctuated amid an unexpected decline in jobless claims, while European equities plunged and the euro rose on concern additional stimulus will fail to boost inflation and revive the economy.

A medical researcher turned biotech analyst highlights several companies with unique diagnostic and therapeutic technologies.

The average large cap score is 60.74, above the four week moving average score of 58.93. The average large cap is trading -9.5% below its 52 week high, 3.27% above its 200 dma, has 3.87 days to cover short, and is expected to post EPS growth of 13.34% next year.

The average large cap stock score is 56.57, below the four week moving average score of 57.67. The average large cap is trading -10.53% below its 52 week high, 2.23% above its 200 dma, has 3.87 days to cover held short, and is expected to grow EPS by 13.48% next year.

The average large cap score pops to 59.86 this week, moving it above the four week moving average score of 58.23. The average large cap is trading -10.5% below its 52 week high, 2.78% above its 200 dma, has 4.09 days to cover held short, and is expected to post EPS growth of 13.96% next year.

INCY is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel therapeutics. Since the Trend Spotter signaled a buy on 10/16 the stock gained 68.47%.